FFCP PHASE1:Hg19::chr2:220594691..220594695,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=not supported | |||
|DPIdataset=robust | |||
|EntrezGene= | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC= | |||
|TSSclassifier=not | |||
|UniProt= | |||
|association_with_transcript=-136bp_to_ENST00000442416_5end | |||
|coexpression_cluster_id=C42 | |||
|description=CAGE_peak_4_at_ENST00000442416_5end | |||
|id=chr2:220594691..220594695,+ | |||
|ontology_enrichment_celltype=CL:0000082!6.95e-12!19 | |||
|ontology_enrichment_celltype_v019=CL:0000082;6.95e-12;19 | |||
|ontology_enrichment_celltype_v019_2=CL:0000082,6.95e-12,19 | |||
|ontology_enrichment_development_v019=UBERON:0008947;2.67e-08;29!UBERON:0001041;4.53e-08;30 | |||
|ontology_enrichment_disease=DOID:5409!3.10e-50!4;DOID:1325!1.78e-29!7;DOID:3904!1.78e-29!7;DOID:3905!2.62e-23!9;DOID:1324!1.22e-14!15;DOID:0050615!8.02e-14!16 | |||
|ontology_enrichment_disease_v019=DOID:5409;3.10e-50;4!DOID:1325;1.78e-29;7!DOID:3904;1.78e-29;7!DOID:3905;2.62e-23;9!DOID:1324;1.22e-14;15!DOID:0050615;8.02e-14;16 | |||
|ontology_enrichment_disease_v019_2=DOID:5409,3.10e-50,4;DOID:1325,1.78e-29,7;DOID:3904,1.78e-29,7;DOID:3905,2.62e-23,9;DOID:1324,1.22e-14,15;DOID:0050615,8.02e-14,16 | |||
|ontology_enrichment_uberon=UBERON:0004802!6.95e-12!19;UBERON:0000115!6.95e-12!19;UBERON:0002048!1.80e-10!22;UBERON:0000117!1.80e-10!22;UBERON:0000171!1.80e-10!22;UBERON:0000170!1.80e-10!22;UBERON:0005597!1.80e-10!22;UBERON:0000118!1.80e-10!22;UBERON:0004807!1.52e-08!28;UBERON:0005178!2.74e-07!34;UBERON:0002224!2.74e-07!34;UBERON:0005181!4.03e-07!35;UBERON:0005153!8.21e-07!37 | |||
|ontology_enrichment_uberon_v019=UBERON:0004802;6.95e-12;19!UBERON:0000115;6.95e-12;19!UBERON:0002048;1.80e-10;22!UBERON:0004807;1.80e-10;22!UBERON:0000117;1.80e-10;22!UBERON:0000171;1.80e-10;22!UBERON:0000170;1.80e-10;22!UBERON:0005178;2.32e-07;34!UBERON:0005181;2.32e-07;35!UBERON:0002224;2.32e-07;34 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0004802,6.95e-12,19;UBERON:0000115,6.95e-12,19;UBERON:0002048,1.80e-10,22;UBERON:0000117,1.80e-10,22;UBERON:0000171,1.80e-10,22;UBERON:0000170,1.80e-10,22;UBERON:0005597,1.80e-10,22;UBERON:0000118,1.80e-10,22;UBERON:0004807,1.52e-08,28;UBERON:0005178,2.74e-07,34;UBERON:0002224,2.74e-07,34;UBERON:0005181,4.03e-07,35;UBERON:0005153,8.21e-07,37 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.71070596893504,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p4@ENST00000442416 | |||
}} |
Revision as of 08:50, 21 January 2014
Short description: | p4@ENST00000442416 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | No |
Description: | CAGE_peak_4_at_ENST00000442416_5end |
Coexpression cluster: | C42_small_lung_maxillary_pharyngeal_Mesenchymal_Wilms_colon |
Association with transcript: | -136bp_to_ENST00000442416_5end |
EntrezGene: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
epithelial cell of lung | 6.95e-12 | 19 |
Ontology term | p-value | n |
---|---|---|
respiratory tract epithelium | 6.95e-12 | 19 |
lung epithelium | 6.95e-12 | 19 |
lung | 1.80e-10 | 22 |
respiratory tube | 1.80e-10 | 22 |
respiration organ | 1.80e-10 | 22 |
pair of lungs | 1.80e-10 | 22 |
lung primordium | 1.80e-10 | 22 |
lung bud | 1.80e-10 | 22 |
respiratory system epithelium | 1.52e-08 | 28 |
thoracic cavity element | 2.74e-07 | 34 |
thoracic cavity | 2.74e-07 | 34 |
thoracic segment organ | 4.03e-07 | 35 |
epithelial bud | 8.21e-07 | 37 |
Ontology term | p-value | n |
---|---|---|
lung small cell carcinoma | 3.10e-50 | 4 |
bronchus cancer | 1.78e-29 | 7 |
bronchogenic carcinoma | 1.78e-29 | 7 |
lung carcinoma | 2.62e-23 | 9 |
lung cancer | 1.22e-14 | 15 |
respiratory system cancer | 8.02e-14 | 16 |